SUPARTZ 3 Trademark

Trademark Overview

On Wednesday, April 15, 2015, a trademark application was filed for SUPARTZ 3 with the United States Patent and Trademark Office. The USPTO has given the SUPARTZ 3 trademark a serial number of 86598585. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Tuesday, November 6, 2018. This trademark is owned by Seikagaku Kogyo Kabushiki Kaisha. The SUPARTZ 3 trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals, namely, injectable sodium hyaluronate solutions for the treatment of articular disorders
supartz 3

General Information

Serial Number86598585
Word MarkSUPARTZ 3
Filing DateWednesday, April 15, 2015
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateTuesday, November 6, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 8, 2015

Trademark Statements

Goods and ServicesPharmaceuticals, namely, injectable sodium hyaluronate solutions for the treatment of articular disorders
Pseudo MarkSUPARTZ THREE

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, April 22, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSeikagaku Kogyo Kabushiki Kaisha
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressChiyoda-ku, Tokyo
JP
Party NameSeikagaku Kogyo Kabushiki Kaisha
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressChiyoda-ku, Tokyo
JP

Trademark Events

Event DateEvent Description
Tuesday, February 12, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 11, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 11, 2019ABANDONMENT - NO USE STATEMENT FILED
Monday, February 11, 2019EXTENSION 5 GRANTED
Wednesday, April 18, 2018EXTENSION 5 FILED
Wednesday, February 6, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, April 18, 2018TEAS EXTENSION RECEIVED
Saturday, October 14, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 12, 2017EXTENSION 4 GRANTED
Thursday, October 12, 2017EXTENSION 4 FILED
Thursday, October 12, 2017TEAS EXTENSION RECEIVED
Tuesday, April 11, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 7, 2017EXTENSION 3 GRANTED
Friday, April 7, 2017EXTENSION 3 FILED
Friday, April 7, 2017TEAS EXTENSION RECEIVED
Tuesday, November 15, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 14, 2016EXTENSION 2 GRANTED
Thursday, October 27, 2016EXTENSION 2 FILED
Monday, November 14, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, October 27, 2016TEAS EXTENSION RECEIVED
Friday, April 22, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 20, 2016EXTENSION 1 GRANTED
Wednesday, April 20, 2016EXTENSION 1 FILED
Wednesday, April 20, 2016TEAS EXTENSION RECEIVED
Tuesday, November 3, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 8, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 8, 2015PUBLISHED FOR OPPOSITION
Wednesday, August 19, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, July 24, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, July 23, 2015ASSIGNED TO EXAMINER
Thursday, April 23, 2015NOTICE OF PSEUDO MARK E-MAILED
Wednesday, April 22, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, April 18, 2015NEW APPLICATION ENTERED IN TRAM

Related Keywords

supartz treatment articular disorders solutions hyaluronate namely injectable sodium pharmaceuticals